11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation.
about
Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repairInsight into the Molecular Imaging of Alzheimer's Disease[18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in ratsPrecision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive AstrocytesModels to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agentsNeuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot studySynthesis and characterization of an MRI Gd-based probe designed to target the translocator protein.Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis.PET imaging of stroke-induced neuroinflammation in mice using [18F]PBR06Synthesis and testing of a p-H2 hyperpolarized 13C probe based on the pyrazolo[1,5-a]pyrimidineacetamide DPA-713, an MRI vector to target the peripheral benzodiazepine receptors.Image derived input function for [18F]-FEPPA: application to quantify translocator protein (18 kDa) in the human brain.Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography.Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA.Current imaging strategies in rheumatoid arthritisTSPO in a murine model of Sandhoff disease: presymptomatic marker of neurodegeneration and disease pathophysiology.Voxel-based imaging of translocator protein 18 kDa (TSPO) in high-resolution PET.Radiosynthesis and in vivo evaluation of two imidazopyridineacetamides, [(11)C]CB184 and [ (11)C]CB190, as a PET tracer for 18 kDa translocator protein: direct comparison with [ (11)C](R)-PK11195.11C-(R)-PK11195 PET imaging of microglial activation and response to minocycline in zymosan-treated rats.Noninvasive molecular imaging of tuberculosis-associated inflammation with radioiodinated DPA-713.Synthesis of [(125)I]iodoDPA-713: a new probe for imaging inflammation.Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06.Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application.Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator ProteinCurrent paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases.The potential of carbon-11 and fluorine-18 chemistry: illustration through the development of positron emission tomography radioligands targeting the translocator protein 18 kDa.Radiopharmaceutical stem cell tracking for neurological diseases.Role of cortical spreading depression in the pathophysiology of migraine.PET imaging of cannabinoid type 2 receptors with [11C]A-836339 did not evidence changes following neuroinflammation in rats.Comparison of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [(18)F]PBR102 and [ (18)F]PBR111 in a model of excitotoxin-induced neuroinflammation.The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo.Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.[11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitisEffects of translocator protein (18 kDa) ligands on microglial activation and neuronal death in the quinolinic-acid-injected rat striatum.Positron emission tomography imaging of neuroinflammation.Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease.Whole body biodistribution and radiation dosimetry in humans of a new PET ligand, [(18)F]-FEPPA, to image translocator protein (18 kDa).The development of an automated and GMP compliant FASTlab™ Synthesis of [(18) F]GE-180; a radiotracer for imaging translocator protein (TSPO).18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke.
P2860
Q24644752-238336B4-4E0C-4506-9541-0E1C1D58DA56Q26765945-CECE4555-6ECA-4DEB-AC48-641E766946E6Q27314677-001BC94A-9BAF-4266-82B1-873BC21FBB2CQ28078621-156E7CDF-7327-4CB3-888C-CA1339F17716Q28391535-50A2DD4B-7F2F-4CA3-82B7-865BF7529F0CQ28392661-9F0577A9-0E89-42A6-89CB-7A6031B40F14Q30585376-7490975D-B50A-40E0-97C9-D1D944C22A68Q33836942-11D0A588-7E24-47A9-A5AA-FF3060079F0EQ33905597-DC516A1C-2479-4183-99F0-2027D2B69546Q33908068-2F6D3E31-A78E-49F4-AE1F-CC54FFDD3AABQ34076710-60E9BA47-03C0-4154-89D2-97B35153D3AAQ34077514-D7949D70-7FE6-4B44-B74C-6016EEBDEB54Q34789872-8EFF597B-81FC-4A50-B194-287FBBB54A2FQ35208026-F1EBA5A4-0A63-4224-8CCD-EF43B5B9BE58Q36008271-D74DE7D5-4391-4FD1-80FC-9B7E0466184CQ36337258-18DBB384-D751-4C09-8B82-B0261F7BAA4DQ36396082-1480668F-838A-4352-8415-A028057995D4Q36655427-317B6E00-5812-4E6B-B222-32B2CA00392DQ36809409-B39ABF7A-8542-4E75-B0CB-7C9F36B36FDFQ37144048-71C83503-C29A-473F-A341-ABA4CF7883F8Q37332188-75672204-AAB4-4F9F-914E-12DE49F3ED4BQ37392949-FE14B94E-988A-4AA1-94EB-02626FD08E17Q37449735-D321B6B5-11A8-45C0-B9CF-5BBE6692009BQ37526428-2799C80E-A9B5-4C4E-8E7C-CA7A57140891Q37584734-112D1EF2-6403-49DF-98EA-B9740407598DQ38018550-D9AC19CD-20F1-4607-9EE2-6A7611604590Q38166963-60E28692-2768-4D9E-8E7E-4D2DED57ED7AQ38225145-B52D3BE3-AE29-45B0-8D0A-03879C1A01BFQ38254739-CC5C617C-F01B-461F-BF0C-F5A20B9E24D5Q38771463-2118CE1D-8252-4BEE-BAEC-DAE8D8A92776Q39127453-41F81B5F-AB85-481D-B039-8F8697B2D7F2Q39407528-B5BADB71-FE5A-4FA9-A80E-2E5075CBFC7FQ40369760-B66F83DC-1343-4CE2-938D-7A6E9A380F6AQ41863477-37B23C85-2BA8-4E1A-A922-0EF87993DF97Q41964688-9A61385B-38C6-41F6-A662-223D70DD7029Q42029944-93319D40-519C-46E5-A540-782AB5D8CD95Q42502183-9FF55246-293D-488B-9113-21DA15377F6CQ44951340-33142E05-AB5C-4C83-A58A-EA2EA2178832Q45401909-5AF18BBA-2606-42D4-978F-F6A255AB20ACQ46709105-557EAE01-DB1A-4F4F-81FA-907606BC99F9
P2860
11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
11C-DPA-713: a novel periphera ...... imaging of neuroinflammation.
@en
11C-DPA-713: a novel periphera ...... imaging of neuroinflammation.
@nl
type
label
11C-DPA-713: a novel periphera ...... imaging of neuroinflammation.
@en
11C-DPA-713: a novel periphera ...... imaging of neuroinflammation.
@nl
prefLabel
11C-DPA-713: a novel periphera ...... imaging of neuroinflammation.
@en
11C-DPA-713: a novel periphera ...... imaging of neuroinflammation.
@nl
P2093
P50
P1476
11C-DPA-713: a novel periphera ...... imaging of neuroinflammation.
@en
P2093
Cyrille Thominiaux
Frédéric Dollé
Marie-Claude Grégoire
Michael Kassiou
Michelle L James
Philippe Hantraye
Régine Trebossen
P304
P356
10.2967/JNUMED.106.036764
P407
P577
2007-04-01T00:00:00Z